Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.
Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...
Inquirer on MSN2d
Controlled drug Ketamine a lifeline for patients with severe depression in S’poreKetamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.
Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel ...
Musk himself has said he uses the drug to treat depression, and he's frequently posted about it on X generally over the years ...
Kevin H. Yang, MD, from the University of California, San Diego, and colleagues used data from the 2015 to 2022 National Survey on Drug Use and Health to examine trends in past-year ketamine use by ...
A multidisciplinary approach, including ketamine withdrawal and symptom management, is essential to mitigate long-term ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback